Bluebird Bio Stock Has 138% Upside, According to 1 Wall Stre

Bluebird Bio Stock Has 138% Upside, According to 1 Wall Street Analyst

Biotech stocks are famously volatile. One analyst feels this one could be volatile enough to produce an outsized gain.

Related Keywords

Fargo Yanan Zhu , , Bluebird Bio , Wells Fargo , Yanan Zhu , Vertex Pharmaceutical Casgevy ,

© 2025 Vimarsana